Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
17.19B | 19.57B | 20.35B | 17.65B | 13.10B | Gross Profit |
12.68B | 14.93B | 15.20B | 13.07B | 9.51B | EBIT |
2.31B | 4.75B | 5.59B | 4.80B | 3.30B | EBITDA |
4.67B | 6.43B | 7.00B | 6.15B | 4.58B | Net Income Common Stockholders |
1.13B | 2.98B | 3.61B | 3.18B | 2.15B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.56B | 3.92B | 4.34B | 5.25B | 3.44B | Total Assets |
43.35B | 41.37B | 33.94B | 31.07B | 28.01B | Total Debt |
20.14B | 17.82B | 11.19B | 9.59B | 9.26B | Net Debt |
16.62B | 13.90B | 6.86B | 4.34B | 5.82B | Total Liabilities |
27.62B | 25.36B | 19.16B | 17.33B | 15.97B | Stockholders Equity |
14.90B | 15.21B | 14.00B | 13.35B | 11.82B |
Cash Flow | Free Cash Flow | |||
1.40B | 1.85B | 3.21B | 3.94B | 2.10B | Operating Cash Flow |
4.71B | 4.46B | 4.28B | 4.88B | 2.89B | Investing Cash Flow |
-3.19B | -7.30B | -2.77B | -451.50M | -196.50M | Financing Cash Flow |
-1.90B | 2.38B | -2.14B | -2.93B | -1.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $255.33B | 56.16 | 28.67% | 0.98% | 12.98% | 6.62% | |
75 Outperform | €247.70B | 19.73 | 19.53% | 2.69% | -1.71% | -17.20% | |
71 Outperform | €80.93B | 15.54 | 22.73% | 2.90% | -1.71% | -17.39% | |
62 Neutral | €20.99B | 18.53 | 7.52% | 6.72% | -12.12% | -62.09% | |
61 Neutral | $6.59B | 11.77 | 3.06% | 3.98% | 2.56% | -20.85% |